Early temporal short-term memory deficits in double transgenic APP/PS1 mice

Neurobiol Aging. 2012 Jan;33(1):203.e1-11. doi: 10.1016/j.neurobiolaging.2010.07.023. Epub 2010 Sep 2.

Abstract

We tested single APP (Tg2576) transgenic, PS1 (PS1dE9) transgenic, and double APP/PS1 transgenic mice at 3 and 6 months of age on the acquisition of a hippocampal-dependent operant "differential reinforcement of low rate schedule" (DRL) paradigm. In this task mice are required to wait for at least 10 seconds (DRL-10s) between 2 consecutive nose poke responses. Our data showed that while single APP and PS1 transgene expression did not affect DRL learning and performance, mice expressing double APP/PS1 transgenes were impaired in the acquisition of DRL-10s at 6 months, but not at 3 months of age. The same impaired double transgenic mice, however, were perfectly capable of normal acquisition of signaled DRL-10s (SDRL-10s) task, a hippocampal-independent task, wherein mice were required to emit responses when the end of the 10-second delay was signaled by a lighting of the chamber. The age-dependent and early deficits of APP/PS1 mice suggest that the appetitive DRL paradigm is sensitive to the amyloid pathology present in double APP/PS1 mice, and that this mouse line represents a good model with which to study the efficacy of therapeutic strategies against Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / genetics*
  • Aging / psychology*
  • Alzheimer Disease* / metabolism
  • Alzheimer Disease* / pathology
  • Amyloid beta-Protein Precursor / genetics*
  • Amyloid beta-Protein Precursor / metabolism
  • Animals
  • Behavior, Animal
  • Conditioning, Operant
  • Disease Models, Animal*
  • Female
  • Hippocampus / metabolism
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Memory, Short-Term / physiology*
  • Mice
  • Mice, Transgenic / genetics*
  • Presenilin-1 / genetics*
  • Reaction Time
  • Reinforcement Schedule
  • Transgenes / genetics

Substances

  • APP protein, human
  • Amyloid beta-Protein Precursor
  • Presenilin-1